| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accuracy of contrast-enhanced ultrasound liver imaging reporting and data system: a systematic review and meta-analysis
|
Son, Jung Hee
|
|
|
|
6 |
p. 1104-1113
|
artikel
|
| 2 |
A changing paradigm: management and treatment of the HCV/HIV-co-infected patient
|
Abutaleb, Ameer
|
|
2018
|
|
6 |
p. 500-509
|
artikel
|
| 3 |
AKI persistence at 48 h predicts mortality in patients with acute on chronic liver failure
|
Maiwall, Rakhi
|
|
2017
|
|
6 |
p. 529-539
|
artikel
|
| 4 |
Alcoholic hepatitis: should we combine old drugs for better results?
|
Cabezas, Joaquin
|
|
2016
|
|
6 |
p. 851-853
|
artikel
|
| 5 |
Alcohol-related hepatitis admissions decline in 2021 after a 2020 surge attributed to the COVID-19 pandemic
|
Gonzalez, Humberto C.
|
|
|
|
6 |
p. 1637-1644
|
artikel
|
| 6 |
Analysis of viral integration reveals new insights of oncogenic mechanism in HBV-infected intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma
|
Zhao, Linghao
|
|
|
|
6 |
p. 1339-1352
|
artikel
|
| 7 |
APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation
|
Kanda, Tatsuo
|
|
|
|
6 |
p. 649-661
|
artikel
|
| 8 |
APASL practical recommendations for the management of hepatocellular carcinoma in the era of COVID-19
|
Shiina, Shuichiro
|
|
|
|
6 |
p. 920-929
|
artikel
|
| 9 |
A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-naïve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus
|
Lim, Young-Suk
|
|
2016
|
|
6 |
p. 947-955
|
artikel
|
| 10 |
Application of CRISPR-Cas9 based gene editing to study the pathogenesis of colon and liver cancer using organoids
|
Ramakrishna, Gayatri
|
|
|
|
6 |
p. 1309-1317
|
artikel
|
| 11 |
Approach and management of dysnatremias in cirrhosis
|
Bernardi, Mauro
|
|
2018
|
|
6 |
p. 487-499
|
artikel
|
| 12 |
A proposal for T1 subclassification in hepatocellular carcinoma: reappraisal of the AJCC 8th edition
|
Lee, Chao-Wei
|
|
|
|
6 |
p. 1353-1367
|
artikel
|
| 13 |
Are herbals more hepatotoxic than prescription medications?
|
Chen, Vincent L.
|
|
|
|
6 |
p. 1301-1304
|
artikel
|
| 14 |
Association between metabolically healthy obesity and non-alcoholic fatty liver disease
|
Man, Sailimai
|
|
|
|
6 |
p. 1412-1423
|
artikel
|
| 15 |
Association of arterial stiffness with the histological severity of nonalcoholic fatty liver disease
|
Kim, Hack-Lyoung
|
|
|
|
6 |
p. 1048-1056
|
artikel
|
| 16 |
Association of epicardial adipose tissue with non-alcoholic fatty liver disease: a meta-analysis
|
Liu, Bin
|
|
|
|
6 |
p. 757-765
|
artikel
|
| 17 |
A standardized pathological proposal for evaluating microvascular invasion of hepatocellular carcinoma: a multicenter study by LCPGC
|
Sheng, Xia
|
|
|
|
6 |
p. 1034-1047
|
artikel
|
| 18 |
A systematic review and meta-analysis of anticoagulation therapy for portal vein thrombosis in patients with cirrhosis: to treat or not to treat?
|
Dong, Shujie
|
|
|
|
6 |
p. 1356-1375
|
artikel
|
| 19 |
Autoimmune liver diseases in the Asia–Pacific region: Proceedings of APASL symposium on AIH and PBC 2016
|
Tanaka, Atsushi
|
|
2016
|
|
6 |
p. 909-915
|
artikel
|
| 20 |
Budd–Chiari syndrome: a focussed and collaborative approach
|
Mukund, Amar
|
|
2018
|
|
6 |
p. 483-486
|
artikel
|
| 21 |
Budd–Chiari syndrome has different presentations and disease severity during adolescence
|
Shukla, Akash
|
|
2018
|
|
6 |
p. 560-566
|
artikel
|
| 22 |
Cellular and functional loss of liver endothelial cells correlates with poor hepatocyte regeneration in acute-on-chronic liver failure
|
Shubham, Smriti
|
|
|
|
6 |
p. 777-787
|
artikel
|
| 23 |
Circulating tumor cells are associated with poor outcomes in early-stage hepatocellular carcinoma: a prospective study
|
Ha, Yeonjung
|
|
|
|
6 |
p. 726-735
|
artikel
|
| 24 |
Clathrin light chain A facilitates small extracellular vesicle uptake to promote hepatocellular carcinoma progression
|
Xu, Yi
|
|
|
|
6 |
p. 1490-1499
|
artikel
|
| 25 |
Clinical and morpho-molecular classifiers for prediction of hepatocellular carcinoma prognosis and recurrence after surgical resection
|
Zhang, Xiuming
|
|
|
|
6 |
p. 715-725
|
artikel
|
| 26 |
Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection
|
Wranke, Anika
|
|
|
|
6 |
p. 1359-1367
|
artikel
|
| 27 |
Clinic-radiomics model using liver magnetic resonance imaging helps predict chronicity of drug-induced liver injury
|
Fu, Haoshuang
|
|
|
|
6 |
p. 1626-1636
|
artikel
|
| 28 |
Comparable short- and long-term outcomes in deceased-donor and living-donor liver retransplantation
|
Chok, Kenneth Siu Ho
|
|
2017
|
|
6 |
p. 517-522
|
artikel
|
| 29 |
Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia–Pacific region
|
Chen, Tao
|
|
|
|
6 |
p. 695-705
|
artikel
|
| 30 |
Consensus on the secondary prevention of primary liver cancer
|
Nan, Yuemin
|
|
|
|
6 |
p. 1289-1300
|
artikel
|
| 31 |
Correction to: Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update
|
Sarin, Shiv Kumar
|
|
|
|
6 |
p. 826-828
|
artikel
|
| 32 |
Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients
|
Cheng, Huei-Ru
|
|
|
|
6 |
p. 1466-1467
|
artikel
|
| 33 |
Correction to: Infuence of shunt occlusion on liver volume and functions in hyperammonemic cirrhosis patients having large porto-systemic shunts: a randomized control trial
|
Mukund, Amar
|
|
|
|
6 |
p. 1496-1498
|
artikel
|
| 34 |
Correction to: Linking the gut and liver: crosstalk between regulatory T cells and mucosa-associated invariant T cells
|
Atif, Muhammad
|
|
|
|
6 |
p. 1494-1495
|
artikel
|
| 35 |
Correlates of disease-specific knowledge among patients with chronic hepatitis B or hepatitis C infection in India
|
Tamayo, Aracely
|
|
2016
|
|
6 |
p. 988-995
|
artikel
|
| 36 |
Cost-effectiveness analysis of tenofovir disoproxil fumarate for treatment of chronic hepatitis B in China
|
Ke, Weixia
|
|
2016
|
|
6 |
p. 924-936
|
artikel
|
| 37 |
Countdown on hepatitis B elimination by 2030: the global burden of liver disease related to hepatitis B and association with socioeconomic status
|
Cao, Guiying
|
|
|
|
6 |
p. 1282-1296
|
artikel
|
| 38 |
COVID-19 in decompensated cirrhosis
|
Rela, Mohamed
|
|
|
|
6 |
p. 1125-1127
|
artikel
|
| 39 |
Current perspectives on the tumor microenvironment in hepatocellular carcinoma
|
Santhakumar, Cositha
|
|
|
|
6 |
p. 947-957
|
artikel
|
| 40 |
3D automatic liver and spleen assessment in predicting overt hepatic encephalopathy before TIPS: a multi-center study
|
Chen, Xiaoqiong
|
|
|
|
6 |
p. 1545-1556
|
artikel
|
| 41 |
Determination of Turkish norms of psychometric tests for diagnosing minimal hepatic encephalopathy and proposal of a high sensitive screening test battery
|
Özbaş, Burak
|
|
|
|
6 |
p. 1442-1455
|
artikel
|
| 42 |
Development and experimental verification of a prognosis model for cuproptosis-related subtypes in HCC
|
Wang, Yixiu
|
|
|
|
6 |
p. 1435-1447
|
artikel
|
| 43 |
Diagnostic performance of MRI for HCC according to contrast agent type: a systematic review and meta-analysis
|
Kim, Dong Wook
|
|
|
|
6 |
p. 1009-1022
|
artikel
|
| 44 |
Distinct on-treatment HCC risks associated with different decompensation events in HBV patients with cirrhosis
|
Kong, Yuanyuan
|
|
|
|
6 |
p. 1350-1358
|
artikel
|
| 45 |
Diversity of the nucleic acid forms of circulating HBV in chronically infected patients and its impact on viral cycle
|
Sotty, Jules
|
|
|
|
6 |
p. 1259-1272
|
artikel
|
| 46 |
Double-blind placebo-controlled randomized trial of N-acetylcysteine infusion following live donor liver transplantation
|
Thirunavayakalathil, Mohammed Abdullatheef
|
|
|
|
6 |
p. 1075-1082
|
artikel
|
| 47 |
Drug–drug interactions between direct-acting antivirals and co-medications: a territory-wide cohort study
|
Hui, Vicki Wing-Ki
|
|
|
|
6 |
p. 1318-1329
|
artikel
|
| 48 |
Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohort
|
Hsu, Yao-Chun
|
|
|
|
6 |
p. 1297-1307
|
artikel
|
| 49 |
Effect of combination treatment based on interferon and nucleos(t)ide analogues on functional cure of chronic hepatitis B: a systematic review and meta-analysis
|
Liu, Jiaye
|
|
|
|
6 |
p. 958-972
|
artikel
|
| 50 |
Effect of endoscopic variceal obliteration by band ligation on portal hypertensive gastro-duodenopathy: endoscopic and pathological study
|
Elwakil, Reda
|
|
2016
|
|
6 |
p. 965-973
|
artikel
|
| 51 |
Effects of serum branched-chain amino acids on nonalcoholic fatty liver disease and subsequent cardiovascular disease
|
Guo, Fei
|
|
|
|
6 |
p. 1424-1434
|
artikel
|
| 52 |
Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
|
Chon, Hye Yeon
|
|
|
|
6 |
p. 1328-1336
|
artikel
|
| 53 |
Elevated hepatic lipid and interferon stimulated gene expression in HCV GT3 patients relative to non-alcoholic steatohepatitis
|
Shrivastava, Shikha
|
|
2016
|
|
6 |
p. 937-946
|
artikel
|
| 54 |
Ending stigmatizing language in alcohol and liver disease: a liver societies’ statement
|
,
|
|
|
|
6 |
p. 1331-1332
|
artikel
|
| 55 |
Entecavir combining Chinese herbal medicine for HBeAg-positive chronic hepatitis B patients: a randomized, controlled trial
|
Li, Xiaoke
|
|
|
|
6 |
p. 985-996
|
artikel
|
| 56 |
Epidemiology and clinical course of primary biliary cholangitis in the Asia–Pacific region: a systematic review and meta-analysis
|
Zeng, Na
|
|
|
|
6 |
p. 788-799
|
artikel
|
| 57 |
Establishment of a murine model of acute-on-chronic liver failure with multi-organ dysfunction
|
Nautiyal, Nidhi
|
|
|
|
6 |
p. 1389-1401
|
artikel
|
| 58 |
Etiology, outcome and prognostic indicators of acute liver failure in Asian children
|
Ng, Ruey Terng
|
|
|
|
6 |
p. 1390-1397
|
artikel
|
| 59 |
Exosomal miR-199a-5p promotes hepatic lipid accumulation by modulating MST1 expression and fatty acid metabolism
|
Li, Yuhan
|
|
|
|
6 |
p. 1057-1074
|
artikel
|
| 60 |
Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease
|
Azzam, Nahla
|
|
|
|
6 |
p. 1114-1124
|
artikel
|
| 61 |
Finite nucleos(t)ide analog therapy in HBeAg-negative chronic hepatitis B: an emerging paradigm shift
|
Liaw, Yun-Fan
|
|
|
|
6 |
p. 665-673
|
artikel
|
| 62 |
‘First week’ is the crucial period for deciding living donor liver transplantation in patients with acute-on-chronic liver failure
|
Choudhury, Ashok
|
|
|
|
6 |
p. 1376-1388
|
artikel
|
| 63 |
Functionally aberrant dendritic cell subsets and expression of DC-SIGN differentiate acute from chronic HBV infection
|
Sukriti, Sukriti
|
|
2016
|
|
6 |
p. 916-923
|
artikel
|
| 64 |
Generic sofosbuvir/ledipasvir for the treatment of genotype 4 chronic hepatitis C in Egyptian children (9–12 years) and adolescents
|
El-Araby, Hanaa A.
|
|
|
|
6 |
p. 706-714
|
artikel
|
| 65 |
Generic sofosbuvir/ledipasvir for the treatment of genotype 4 chronic hepatitis C in Egyptian children (9–12 years) and adolescents
|
El-Araby, Hanaa A.
|
|
|
|
6 |
p. 706-714
|
artikel
|
| 66 |
Gut microbiota alteration in hepatobiliary diseases: cause-and-effect relationship
|
Guo, Xiaoyan
|
|
|
|
6 |
p. 1305-1308
|
artikel
|
| 67 |
Gut microbiota regulates circadian oscillation in hepatic ischemia–reperfusion injury-induced cognitive impairment by interfering with hippocampal lipid metabolism in mice
|
He, Zhigang
|
|
|
|
6 |
p. 1645-1658
|
artikel
|
| 68 |
HBx mutations emerged during antiviral therapy: a new face of a multifaceted HBV protein?
|
Zhou, Bin
|
|
|
|
6 |
p. 944-946
|
artikel
|
| 69 |
HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort
|
Tanaka, Yasuhito
|
|
|
|
6 |
p. 1023-1033
|
artikel
|
| 70 |
Health-related quality of life improves after entecavir treatment in patients with compensated HBV cirrhosis
|
Wu, Xiaoning
|
|
|
|
6 |
p. 1318-1327
|
artikel
|
| 71 |
Hepatic fibrosis is associated with an increased rate of decline in bone mineral density in men with nonalcoholic fatty liver disease
|
Yoon, Ji Won
|
|
|
|
6 |
p. 1347-1355
|
artikel
|
| 72 |
Hepatic stellate cells: fibrogenic, regenerative or both? Heterogeneity and context are key
|
Bansal, Meena B.
|
|
2016
|
|
6 |
p. 902-908
|
artikel
|
| 73 |
Hepatitis B-positive health-care workers: why they should not switch to non-exposure-prone jobs
|
Jindal, Ankur
|
|
2018
|
|
6 |
p. 520-522
|
artikel
|
| 74 |
Hepatitis B virus genotypes: epidemiological and clinical relevance in Asia
|
Tian, Qiuju
|
|
2016
|
|
6 |
p. 854-860
|
artikel
|
| 75 |
Hepatitis B virus: virology, molecular biology, life cycle and intrahepatic spread
|
Karayiannis, P.
|
|
2017
|
|
6 |
p. 500-508
|
artikel
|
| 76 |
Hepatitis B virus: virology, molecular biology, life cycle and intrahepatic spread
|
Karayiannis, P.
|
|
|
|
6 |
p. 500-508
|
artikel
|
| 77 |
Hepatitis B virus X gene mutants emerge during antiviral therapy and increase cccDNA levels to compensate for replication suppression
|
Lin, Chih-Lang
|
|
|
|
6 |
p. 973-984
|
artikel
|
| 78 |
Hepatitis C genotype 3 disease
|
Kattakuzhy, Sarah
|
|
2016
|
|
6 |
p. 861-870
|
artikel
|
| 79 |
Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients
|
Leonhardt, Silke
|
|
|
|
6 |
p. 1610-1625
|
artikel
|
| 80 |
Hepatocellular carcinoma and non-alcoholic fatty liver disease
|
Golabi, Pegah
|
|
|
|
6 |
p. 688-694
|
artikel
|
| 81 |
Herbal and dietary supplement-induced liver injury in Taiwan: comparison with conventional drug-induced liver injury
|
Huang, Yi-Shin
|
|
|
|
6 |
p. 1456-1465
|
artikel
|
| 82 |
How non-alcoholic fatty liver disease and cirrhosis affect the heart
|
Møller, Søren
|
|
|
|
6 |
p. 1333-1349
|
artikel
|
| 83 |
How to identify the need for liver transplantation in pediatric acute-on-chronic liver failure?
|
Lal, Bikrant Bihari
|
|
2018
|
|
6 |
p. 552-559
|
artikel
|
| 84 |
Identification of blood metabolites linked to the risk of cholelithiasis: a comprehensive Mendelian randomization study
|
Mi, Jiarui
|
|
|
|
6 |
p. 1484-1493
|
artikel
|
| 85 |
Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group
|
Cillo, Umberto
|
|
|
|
6 |
p. 930-943
|
artikel
|
| 86 |
Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial
|
Meng, Fanping
|
|
|
|
6 |
p. 1402-1412
|
artikel
|
| 87 |
Impact of elobixibat on liver tumors, microbiome, and bile acid levels in a mouse model of nonalcoholic steatohepatitis
|
Sugiyama, Yoshiaki
|
|
|
|
6 |
p. 1378-1392
|
artikel
|
| 88 |
Improving survival in ACLF: growing evidence for use of G-CSF
|
Simonetto, D. A.
|
|
2017
|
|
6 |
p. 473-475
|
artikel
|
| 89 |
Live donor liver transplantation for pediatric acute liver failure: challenges and outcomes
|
Pamecha, Viniyendra
|
|
|
|
6 |
p. 1570-1586
|
artikel
|
| 90 |
Long-term cardiovascular outcomes differ across metabolic dysfunction-associated fatty liver disease subtypes among middle-aged population
|
Lee, Hokyou
|
|
|
|
6 |
p. 1308-1317
|
artikel
|
| 91 |
Lymphatic drainage dysfunction is related to clinically significant portal hypertension
|
Ma, Ruixue
|
|
|
|
6 |
p. 1327-1330
|
artikel
|
| 92 |
Lymphatic drainage dysfunction via narrowing of the lumen of cisterna chyli and thoracic duct after luminal dilation
|
Yano, Ryo
|
|
|
|
6 |
p. 1557-1569
|
artikel
|
| 93 |
Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial
|
Shi, Ming
|
|
|
|
6 |
p. 1431-1441
|
artikel
|
| 94 |
Metabolically healthy obese and MAFLD: does weight status alone matter?
|
Pan, Ziyan
|
|
|
|
6 |
p. 1253-1255
|
artikel
|
| 95 |
Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case–control study
|
Liu, Hui-Hui
|
|
|
|
6 |
p. 1337-1346
|
artikel
|
| 96 |
Metal, magnet or transplant: options in primary sclerosing cholangitis with stricture
|
Ahmad, Jawad
|
|
2018
|
|
6 |
p. 510-519
|
artikel
|
| 97 |
MEX3A determines in vivo hepatocellular carcinoma progression and induces resistance to sorafenib in a Hippo-dependent way
|
Fang, Shiji
|
|
|
|
6 |
p. 1500-1518
|
artikel
|
| 98 |
MicroRNA-744/transforming growth factor β1 relationship regulates liver cirrhosis
|
Ren, Shuang
|
|
|
|
6 |
p. 814-825
|
artikel
|
| 99 |
Molecular evolution in different subtypes of multifocal hepatocellular carcinoma
|
Tang, Xia
|
|
|
|
6 |
p. 1429-1443
|
artikel
|
| 100 |
Mother-to-infant transmission of hepatitis B virus: challenges and perspectives
|
Shih, Yi-Fen
|
|
2017
|
|
6 |
p. 481-484
|
artikel
|
| 101 |
New progress towards elimination of mother-to-child transmission of hepatitis B virus in China
|
Zheng, Hui
|
|
|
|
6 |
p. 1273-1281
|
artikel
|
| 102 |
Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis
|
Wang, Qianyi
|
|
|
|
6 |
p. 766-776
|
artikel
|
| 103 |
Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patients
|
Lin, Kong-Ying
|
|
|
|
6 |
p. 1477-1489
|
artikel
|
| 104 |
Platelets in acute liver failure: an innocent bystander or instigator?
|
Maiwall, Rakhi
|
|
|
|
6 |
p. 1256-1258
|
artikel
|
| 105 |
Portal hypertensive gastropathy after variceal eradication: more bleeding risk or just more reddening?
|
Primignani, Massimo
|
|
2016
|
|
6 |
p. 847-850
|
artikel
|
| 106 |
Post-transplant inflammatory cytokine signature adds value for predicting tumor recurrence after liver transplantation for hepatocellular carcinoma
|
Ng, Kevin Tak-Pan
|
|
|
|
6 |
p. 1596-1609
|
artikel
|
| 107 |
Post-treatment fibrotic modifications overwhelm pretreatment liver fibrosis in predicting HCC in CHC patients with curative antivirals
|
Huang, Chung-Feng
|
|
2018
|
|
6 |
p. 544-551
|
artikel
|
| 108 |
Prediction of the very early occurrence of HCC right after DAA therapy for HCV infection
|
Ooka, Yoshihiko
|
|
2018
|
|
6 |
p. 523-530
|
artikel
|
| 109 |
Prednisolone plus S-adenosil-l-methionine in severe alcoholic hepatitis
|
Tkachenko, Petr
|
|
2016
|
|
6 |
p. 983-987
|
artikel
|
| 110 |
Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis
|
Li, Chao
|
|
|
|
6 |
p. 736-747
|
artikel
|
| 111 |
Prevalence and incidence of MAFLD and associated anthropometric parameters among prepubertal children of the Shanghai Birth Cohort
|
Zeng, Jing
|
|
|
|
6 |
p. 1416-1428
|
artikel
|
| 112 |
Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus β-blocker
|
Chen, Yan
|
|
|
|
6 |
p. 1379-1389
|
artikel
|
| 113 |
Primary biliary cholangitis: a comprehensive overview
|
Lleo, Ana
|
|
2017
|
|
6 |
p. 485-499
|
artikel
|
| 114 |
Prognosis factors of predicting survival in spontaneously ruptured hepatocellular carcinoma
|
Wang, Peng
|
|
|
|
6 |
p. 1330-1338
|
artikel
|
| 115 |
Pure laparoscopic versus open left lateral hepatectomy in pediatric living donor liver transplantation: a review and meta-analysis
|
Sha, Meng
|
|
|
|
6 |
p. 1587-1595
|
artikel
|
| 116 |
Radiotherapy prior to or after transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a randomized controlled trial
|
Guo, Lei
|
|
|
|
6 |
p. 1368-1378
|
artikel
|
| 117 |
Recompensation in treatment-naïve HBV-related decompensated cirrhosis: a 5-year multi-center observational study comparing patients with ascites and bleeding
|
He, Zhiying
|
|
|
|
6 |
p. 1368-1377
|
artikel
|
| 118 |
Reduction of natural killer cells is associated with poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure
|
Li, Hua-Jie
|
|
|
|
6 |
p. 1398-1411
|
artikel
|
| 119 |
Refining the role of epicardial adipose tissue in non-alcoholic fatty liver disease
|
Eslam, Mohammed
|
|
|
|
6 |
p. 662-664
|
artikel
|
| 120 |
Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines
|
Teng, Wei
|
|
|
|
6 |
p. 1421-1430
|
artikel
|
| 121 |
Risks of hepatocellular carcinoma and cirrhosis-associated complications in patients with rheumatoid arthritis: a 10-year population-based cohort study in Taiwan
|
Hsu, Ching-Sheng
|
|
2018
|
|
6 |
p. 531-543
|
artikel
|
| 122 |
Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B
|
Huang, Yi-Wen
|
|
|
|
6 |
p. 997-1008
|
artikel
|
| 123 |
Sarcopenia and fatty liver disease
|
Kim, Jung A.
|
|
|
|
6 |
p. 674-687
|
artikel
|
| 124 |
Scenarios to manage the hepatitis C disease burden and associated economic impact of treatment in Turkey
|
Örmeci, Necati
|
|
2017
|
|
6 |
p. 509-516
|
artikel
|
| 125 |
Second primary cancer after liver transplantation in hepatocellular carcinoma: a nationwide population-based study
|
Heo, Jaesung
|
|
2017
|
|
6 |
p. 523-528
|
artikel
|
| 126 |
Sepsis in cirrhosis: emerging concepts in pathogenesis, diagnosis and management
|
Philips, Cyriac Abby
|
|
2016
|
|
6 |
p. 871-882
|
artikel
|
| 127 |
Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy
|
Nagata, Hiroko
|
|
2016
|
|
6 |
p. 956-964
|
artikel
|
| 128 |
Sex and regional disparities in incidence of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis
|
Yan, Lun-Jie
|
|
|
|
6 |
p. 1413-1420
|
artikel
|
| 129 |
Significant decrease in Faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: a large BMI- and sex-matched population study
|
Iino, Chikara
|
|
|
|
6 |
p. 748-756
|
artikel
|
| 130 |
Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis
|
Maslennikov, Roman
|
|
2018
|
|
6 |
p. 567-576
|
artikel
|
| 131 |
Targeting NAD+ metabolism of hepatocellular carcinoma cells by lenvatinib promotes M2 macrophages reverse polarization, suppressing the HCC progression
|
Sun, Qingcan
|
|
|
|
6 |
p. 1444-1460
|
artikel
|
| 132 |
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
|
Eslam, Mohammed
|
|
|
|
6 |
p. 889-919
|
artikel
|
| 133 |
The causes of death in patients with nonalcoholic steatohepatitis following liver transplantation stratified using pre-liver transplant BMI
|
Lee, David Uihwan
|
|
|
|
6 |
p. 1393-1415
|
artikel
|
| 134 |
The clinical implications of pre-liver transplant diabetes on post-liver transplant outcomes in patients with NASH: analysis of the UNOS database
|
Lee, David Uihwan
|
|
|
|
6 |
p. 1448-1457
|
artikel
|
| 135 |
The MAPS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with targeted therapy plus immunotherapy
|
Ouyang, Jingzhong
|
|
|
|
6 |
p. 1519-1531
|
artikel
|
| 136 |
The potential role of liver stem cells in initiation of primary liver cancer
|
Zhi, Xiao-Song
|
|
2016
|
|
6 |
p. 893-901
|
artikel
|
| 137 |
The predictors of post-transplant coronary events among liver transplant recipients
|
Malik, Mohammad U.
|
|
2016
|
|
6 |
p. 974-982
|
artikel
|
| 138 |
Therapeutic implications of granulocyte colony stimulating factor in patients with acute-on-chronic liver failure: increased survival and containment of liver damage
|
Saha, Biplob Kumar
|
|
2017
|
|
6 |
p. 540-546
|
artikel
|
| 139 |
Therapeutic role of FNDC5/irisin in attenuating liver fibrosis via inhibiting release of hepatic stellate cell-derived exosomes
|
Liao, Xin
|
|
|
|
6 |
p. 1659-1671
|
artikel
|
| 140 |
Thromboelastometry in patients with advanced chronic liver disease stratified by severity of portal hypertension
|
Raeven, Pierre
|
|
|
|
6 |
p. 1083-1092
|
artikel
|
| 141 |
Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality
|
Kim, Do Young
|
|
2016
|
|
6 |
p. 883-892
|
artikel
|
| 142 |
Treatment with carvedilol improves survival of patients with acute-on-chronic liver failure: a randomized controlled trial
|
Kumar, Manoj
|
|
|
|
6 |
p. 800-813
|
artikel
|
| 143 |
Two-year risedronate treatment for osteoporosis in patients with esophageal varices: a non-randomized clinical trial
|
Santos, Lívia Alves Amaral
|
|
|
|
6 |
p. 1458-1467
|
artikel
|
| 144 |
Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials
|
Bai, Zhaohui
|
|
|
|
6 |
p. 1468-1483
|
artikel
|
| 145 |
Viral factors for HBV mother-to-child transmission
|
Park, James S.
|
|
2017
|
|
6 |
p. 476-480
|
artikel
|
| 146 |
Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosis
|
Simbrunner, Benedikt
|
|
|
|
6 |
p. 1093-1103
|
artikel
|
| 147 |
Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome
|
Simbrunner, Benedikt
|
|
|
|
6 |
p. 1532-1544
|
artikel
|
| 148 |
Whole-exome sequencing reveals the metastatic potential of hepatocellular carcinoma from the perspective of tumor and circulating tumor DNA
|
Zhou, Chenhao
|
|
|
|
6 |
p. 1461-1476
|
artikel
|
Tijdschrift beschrijving